MTOR and pancreatic ductal adenocarcinoma: Research carried out of animal models have demonstrated that agents targeting mTOR pathway can lead to significant inhibition of proliferation, differentiation, and tumor progression in specific pancreatic ductal adenocarcinoma subpopulations [35].